A new study published in the Journal of American Medical Association revealed that the necessity of including smoking cessation into addiction treatment programs is demonstrated by the 30% increased chance of recovery from non-tobacco addictions among smokers with drug use disorders who stopped cigarettes. People with other substance use disorders (SUDs) are more likely to […]
Researchers at the Icahn School of Medicine at Mount Sinai have found that prenatal exposure to acetaminophen may increase the risk of neurodevelopmental disorders, including autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD), in children. The study, published today in BMC Environmental Health, is the first to apply the rigorous Navigation Guide methodology to systematically evaluate […]
A recent real-world study conducted in China has confirmed that baricitinib, a Janus kinase (JAK) inhibitor, significantly improves hair regrowth in patients with various forms of alopecia areata, including totalis, universalis, and eyebrow/eyelash loss. The study observed a substantial reduction in the Severity of Alopecia Tool (SALT) scores, with an average improvement from 70.21 at […]
Physical activity (PA) is associated with significant positive impacts on both physical and mental health in non-pregnant populations. Several health organisations have strongly suggested that PA is directly correlated to a lower risk of heart disease, diabetes type 2, metabolic syndrome, anxiety, and some types of cancer. Considering the physical changes that occur during pregnancy, […]
China: A team from The Second Clinical College of Guangzhou University of Chinese Medicine, led by Rui Jiang, has documented a rare case of bevacizumab-associated glomerular microangiopathy (Bmab-GMA) in BMC Nephrology, adding to growing evidence of serious kidney-related side effects tied to the cancer drug. The case involved a 59-year-old man with stage IIIA right […]
The FDA has approved oral brensocatib (Brinsupri) for adults and children 12+ with non-cystic fibrosis bronchiectasis. As a first-in-class reversible DPP-1 inhibitor, it targets the disease’s underlying inflammation, which can cause permanent lung damage and affects about 500,000 people in the U.S. BRINSUPRI is the first and only FDA-approved treatment for NCFB, giving hundreds of […]
An autopsy study published in the Journal of American Medical Association revealed that higher adherence to the Mediterranean–Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet was associated with lower odds of hippocampal sclerosis and less dementia at death, suggesting the diet’s protective effect may be partly mediated through reduced hippocampal damage. Severe neuronal […]
USA: Researchers have found in a new study that inserting a contraceptive implant within the first 24 hours postpartum is safe for breastfeeding individuals. This finding supports users, healthcare providers, and hospitals in offering placement at a time that best meets the user’s needs. The study was published online in the American Journal of Obstetrics […]
Even though microbial keratitis is a preventable cause of blindness, it’s a complex infection to treat, and many patients have lasting vision impairment. Previous studies have identified several risk factors for reduced vision after treatment, including delays in symptom onset, longer duration of symptoms and existing eye disease. However, these studies were restricted to one […]
Turkey: A retrospective single-center study published in BMC Ophthalmology has highlighted the potential role of intravitreal dexamethasone implants as an adjunctive therapy in managing Coats’ disease alongside conventional ablative treatments. The research, conducted by Ozlem Ural Fatihoglu and colleagues from the Department of Ophthalmology at Dokuz Eylül University, İzmir, Turkey, assessed the efficacy and safety […]